The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
Premium- We have written about the pressure on shares of Elan Corp. (NYSE:ELN), which has been taking place in advance of the expected market entry of … Continue Reading
Read nowLong Ideas - Deerfield Capital reported a 6.2% stake in InterMune (NASDAQ:ITMN) on Tuesday, causing shares of the biotechnology company to climb 10% in the following trading session. … Continue Reading
Read now- Shares of St. Jude Medical (NYSE:STJ) opened 6% lower Wednesday morning following the company’s quarterly report and conference call, which included discussion of a potential … Continue Reading
Read nowLong Ideas - On Tuesday, Gattex (teduglutide) received a unanimous recommendation for approval from the FDA’s Gastrointestinal Drugs Advisory Committee, suggesting that the FDA may officially approve the … Continue Reading
Read now- In a move of self-preservation, Peregrine Pharmaceuticals (NASDAQ:PPHM) announced Wednesday that it raised $14.3 million in gross proceeds through an ATM (At The Market) agreement … Continue Reading
Read now- The FDA has raised safety concerns about tumors spotted in patients treated with the developmental LDL-lowering therapy, Kynamro. The drug is under review after a … Continue Reading
Read now- Shares of ArQule (NASDAQ:ARQL) are up 8% on news that the FDA has agreed to a Special Protocol Assessment for the company’s planned Phase III tivantinib trial. … Continue Reading
Read now
